Bank Of Nova Scotia Biomarin Pharmaceutical Inc Transaction History

Bank Of Nova Scotia

$47.4 Billion
Q3 2024

A detailed history of Bank Of Nova Scotia transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Bank Of Nova Scotia holds 13,424 shares of BMRN stock, worth $851,350. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,424

Previous 14,004 4.14%

Holding current value

$851,350

Previous $1.15 Million 18.14%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$69.02 - $93.84 $40,031 - $54,427	-580 Reduced 4.14%	13,424 $943,000
Q2 2024 Aug 14, 2024	SELL	$74.43 - $92.22 $10.4 Million - $12.9 Million	-139,978 Reduced 90.91%	14,004 $1.15 Million
Q1 2024 May 14, 2024	SELL	$83.81 - $99.0 $10.3 Million - $12.2 Million	-123,486 Reduced 44.5%	153,982 $13.4 Million
Q4 2023 Feb 12, 2024	BUY	$76.22 - $98.51 $351,450 - $454,229	4,611 Added 1.69%	277,468 $26.8 Million
Q3 2023 Nov 14, 2023	BUY	$85.07 - $94.48 $12.4 Million - $13.8 Million	145,685 Added 114.56%	272,857 $24.1 Million
Q2 2023 Aug 03, 2023	BUY	$86.68 - $100.3 $2,080 - $2,407	24 Added 0.02%	127,172 $11 Million
Q1 2023 May 11, 2023	SELL	$87.74 - $117.27 $7.8 Million - $10.4 Million	-88,901 Reduced 41.15%	127,148 $12.4 Million
Q4 2022 Feb 09, 2023	BUY	$80.93 - $108.63 $17.1 Million - $23 Million	211,797 Added 4981.11%	216,049 $22.4 Million
Q3 2022 Nov 10, 2022	SELL	$82.16 - $96.94 $34,178 - $40,327	-416 Reduced 8.91%	4,252 $360,000
Q2 2022 Aug 08, 2022	BUY	$71.48 - $86.85 $333,668 - $405,415	4,668 New	4,668 $399,000
Q2 2022 Aug 05, 2022	SELL	$71.48 - $86.85 $422,160 - $512,936	-5,906 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$74.28 - $92.69 $171,661 - $214,206	2,311 Added 64.28%	5,906 $455,000
Q4 2021 Feb 11, 2022	BUY	$71.72 - $91.47 $257,833 - $328,834	3,595 New	3,595 $320,000

Others Institutions Holding BMRN

# of Institutions

635

Shares Held

178M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Nova Scotia with notifications on news.

Account

Bank Of Nova Scotia Biomarin Pharmaceutical Inc Transaction History